Segui
Giuseppe Cabibbo MD, PhD
Giuseppe Cabibbo MD, PhD
Email verificata su unipa.it - Home page
Titolo
Citata da
Citata da
Anno
A meta‐analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma
G Cabibbo, M Enea, M Attanasio, J Bruix, A Craxý, C CammÓ
Hepatology 51 (4), 1274-1283, 2010
5392010
Field‐practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy
M Iavarone, G Cabibbo, F Piscaglia, C Zavaglia, A Grieco, E Villa, ...
Hepatology, 2011
4182011
Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease
F Bortolotti, G Verucchi, C CammÓ, G Cabibbo, L Zancan, G Indolfi, ...
Gastroenterology 134 (7), 1900-1907, 2008
342*2008
Incidence of hepatocellular carcinoma in patients with HCV-associated cirrhosis treated with direct-acting antiviral agents
V Calvaruso, G Cabibbo, I Cacciola, S Petta, S Madonia, A Bellia, F TinŔ, ...
Gastroenterology 155 (2), 411-421. e4, 2018
3252018
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study
E Villa, R Critelli, B Lei, G Marzocchi, C CammÓ, G Giannelli, P Pontisso, ...
Gut 65 (5), 861-869, 2016
2312016
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study
A Vitale, P Burra, AC Frigo, F Trevisani, F Farinati, G Spolverato, M Volk, ...
Journal of hepatology 62 (3), 617-624, 2015
2192015
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules
E Terzi, M Iavarone, M Pompili, L Veronese, G Cabibbo, M Fraquelli, ...
Journal of hepatology 68 (3), 485-492, 2018
2132018
HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: a meta-analysis
AG Singal, E Zhang, M Narasimman, NE Rich, AK Waljee, Y Hoshida, ...
Journal of hepatology 77 (1), 128-139, 2022
1702022
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients
G Cabibbo, C Celsa, V Calvaruso, S Petta, I Cacciola, MR Cannav˛, ...
Journal of hepatology 71 (2), 265-273, 2019
167*2019
Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?
G Marisi, A Cucchetti, P Ulivi, M Canale, G Cabibbo, L Solaini, FG Foschi, ...
World journal of gastroenterology 24 (36), 4152, 2018
1662018
The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data
F Fiorica, F Cartei, M Enea, A Licata, G Cabibbo, B Carau, A Liboni, ...
Cancer treatment reviews 33 (8), 729-740, 2007
1662007
Effects of eradicating hepatitis C virus infection in patients with cirrhosis differ with stage of portal hypertension
V Di Marco, V Calvaruso, D Ferraro, MG Bavetta, G Cabibbo, E Conte, ...
Gastroenterology 151 (1), 130-139. e2, 2016
1612016
Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population
S Bruno, V Di Marco, M Iavarone, L Roffi, A Crosignani, V Calvaruso, ...
Journal of Hepatology 64 (6), 1217-1223, 2016
1582016
Staging systems of hepatocellular carcinoma: a review of literature
M Maida, E Orlando, C CammÓ, G Cabibbo
World Journal of Gastroenterology: WJG 20 (15), 4141, 2014
1532014
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct‐acting antivirals? A prospective multicentre study
G Cabibbo, S Petta, V Calvaruso, I Cacciola, MR Cannav˛, S Madonia, ...
Alimentary pharmacology & therapeutics 46 (7), 688-695, 2017
1362017
Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib
M Iavarone, G Cabibbo, M Biolato, C Della Corte, M Maida, M Barbara, ...
Hepatology 62 (3), 784-791, 2015
1352015
Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study
C Camma, V Di Marco, A Orlando, L Sandonato, A Casaril, P Parisi, ...
Journal of hepatology 42 (4), 535-540, 2005
135*2005
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma
A Cucchetti, F Trevisani, A Pecorelli, V Erroi, F Farinati, F Ciccarese, ...
Journal of Hepatology 61 (2), 333-341, 2014
1332014
Development and validation of a new prognostic system for patients with hepatocellular carcinoma
F Farinati, A Vitale, G Spolverato, TM Pawlik, T Huo, YH Lee, AC Frigo, ...
PLoS medicine 13 (4), e1002006, 2016
1312016
Epidemiology, risk factors and surveillance of hepatocellular carcinoma
G Cabibbo, A Craxi
Eur Rev Med Pharmacol Sci 14 (4), 352-355, 2010
1312010
Il sistema al momento non pu˛ eseguire l'operazione. Riprova pi¨ tardi.
Articoli 1–20